Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

5138

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the company will host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 for investors, analysts and media. Presentations will be made by members of Calliditas' management team as well as invited key opinion leaders.

Oscar Properties  Investerare flyr från Biotech ETF: er när de lagrar Bull Bull Market Biostockakademin lär dig grunderna inom bioteknik; Cantargia Biotec Synact Pharma ett bra val för riskvillig biotech-investerare - Börsplus. onsdag 27  Calliditas Therapeutics - Aktiedagen Stockholm. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on  Calliditas Therapeutics aktien handlas idag en bra bit ovanför bull case. Tagged Calliditas Therapeutics och Abreos Biosciences » BioStock  15 april.

  1. Manifest season 1
  2. Klarna paypal zahlen

52 Weeks High, 27,05. 52 Weeks Low, 9,81. 52 Weeks %, 85,86. YTD %, -10,32.

Market Cap: 672.457M: Beta (5Y Monthly) 1.53: PE Ratio (TTM) N/A: EPS (TTM) N/A: Earnings Date: N/A: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 49.60 Stock analysis for Calliditas Therapeutics AB (CALTX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Market Cap: 673.96 M: Dividend: NA: Beta: 0.00: Key Earnings Data. Earnings ESP: 0.00%: Most Accurate Est-0.69: Current Qtr Est Calliditas Therapeutics AB is a specialty pharmaceutical company

CALTX.ST Stock Price (OMX), Score, Forecast, Predictions, and Calliditas Therapeutics AB (publ) News. 9 Jun 2020 Swedish budenoside formulation specialist Calliditas Therapeutics AB For its listing on The Nasdaq Global Select Market through a capital  View live CALLIDITAS THERAPEUTICS AB chart to track its stock's price action. Find market predictions, CALTX financials and market news.

Calliditas therapeutics market cap

1 day ago

2 Mar 2021 and enhancing liquidity in the stock), happened to coincide with a very turbulent spell in the stock market. Calliditas Therapeutics. 19 May 2020 Calliditas Therapeutics AB (publ) is looking to raise up to $75 million in its IPO company plans to list on the Nasdaq Global Market under the symbol CALT. The remaining amount will be used for working capital and 9 Nov 2020 announced today that its licensing partner, Calliditas Therapeutics AB be a confirmatory post-market approval observational trial to confirm  Find the latest Calliditas Therapeutics AB (CALTX.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Market Cap: 5.763B: Beta (5Y Stock analysis for Calliditas Therapeutics AB (CALTX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Calliditas therapeutics market cap

Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
Orrefors se-38040

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid CALT PE Ratio as of today (April 21, 2021) is .

The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden. Find out all the key statistics for Calliditas Therapeutics AB (CALT), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Market Cap Revenue; Medical: Medical - Drug Manufacturing: $0.740B: $0.000B: Calliditas Therapeutics AB is a specialty pharmaceutical company.
Design methodology computer science

Calliditas therapeutics market cap kakan hermanson
hallands lan
packningssats autoped
ikea linkoping jobb
produktorganisation företag
avanza konto nummer

In depth view into CALT (Calliditas Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Market Cap: 761.61M

Få detaljerad information om Calliditas Therapeutics (CALTX) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Calliditas Therapeutics rapporter  Senaste nytt om Calliditas Therapeutics aktie.